Millions of people worldwide are living with #HepatitisC. On #WorldHepatitisDay, learn about our commitment to treating #HCV and the role of partnerships to achieve the World Health Organization’s HCV elimination goal by 2030. ⬇ [Video description: Interview with Brian Conway, medical director, Vancouver Infectious Diseases Centre. On-screen text reads, “Globally, an estimated 50 million people have HCV, with about 1 million new infections occurring per year. Join us as we work to help eliminate Hepatitis C.”]
About us
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Website
-
http://www.abbvie.com
External link for AbbVie
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- North Chicago, Illinois
- Type
- Public Company
- Specialties
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care
Locations
Employees at AbbVie
Updates
-
To effectively work together to find cures, researchers need a shared understanding of what a cure really is – and what it isn’t. See what our researchers look for and how they collaborate to find cures faster: https://bit.ly/3LG7rtt #WorldHepatitisDay [Video description: On-screen text reads, “The pathway to a cure” followed by 5 steps along the pathway: precedented symptom relief; unprecedented symptom relief; transformative therapies; on treatment, disease-free state; cure.]
-
JUST IN: The European Medicines Agency approved our latest treatment for adults with moderately to severely active #UlcerativeColitis. Read more: https://bit.ly/3WnZb6x #IBD [Video description: On-screen text reads, “Immunology News. European Commission Approval in Ulcerative Colitis.”]
-
On #NationalInternDay, hear some of our #interns share why they joined our summer program — where they gain hands-on experience, learn from industry leaders and contribute to projects that make a difference in patients’ lives. Join us: https://bit.ly/4cXpyXP #AbbVieLife [Video description: Six AbbVie interns wearing blue sunglasses share why they joined our summer internship program.]
-
"Our business continues to perform exceptionally well, with second-quarter results meaningfully ahead of our expectations," said Rob Michael, our CEO. Learn more about our Q2 2024 #FinancialResults: https://lnkd.in/g95ZTkJ8 $ABBV #earnings [Image description: Summary of AbbVie's Q2 2024 Financial Results, including Raised Adjusted EPS Guidance Range, Net Revenues by Therapeutic Area and Adjusted R&D Investment.]
-
Leading up to #WorldHepatitisDay, we’re raising awareness of the impact of #MentalHealth and addiction in #HCV care. Learn more about the importance of addressing mental health in HCV. ⬇ [Video description: Interview with Filipe Calinas, gastroenterologist and pathologist, Certeario Hospital. On-screen text reads, “Cognitive decline and psychological disorders affect up to 50% of people with HCV. We are committed to improving the lives of people living with Hepatitis C.”]
-
From San Francisco to Colombia to Finland (and more), our employees around the world celebrated #PrideMonth in the communities where we work and live. Learn how our PRIDE employee resource group fosters a sense of culture and community for our #LGBTQ+ employees year-round: https://bit.ly/3A3bv4i #BelongAtAbbVie #AbbVieLife
-
-
-
-
-
+3
-
-
How does the #culture of our R&D organization resonate with Laura Munteanu, medical director? Hear her explain in “R&D is Me,” a series highlighting the #career journeys of our R&D employees. Explore our roles: https://bit.ly/3xVFcUA [Video description: Laura Munteanu, medical director, shares what resonates with her about the culture in R&D. On-screen text ends with, "R&D is me."]
-
It’s critical that we all work together to reach the World Health Organization’s goal of #HepatitisC elimination by 2030. Ahead of #WorldHepatitisDay, we’re emphasizing our focus on #HCV elimination and advancing progress in the global community. Hear more below. [Video description: An interview with Dimitri Semizarov, global medical affairs therapeutic area lead at AbbVie. On-screen text reads, “Together, global leaders can help eliminate hepatitis C by 2030. Join us in helping move the world closer to eliminating Hepatitis C.”]
-
Through our sponsored #research conducted by the PD Avengers, we gained a deeper understanding of how #ParkinsonsDisease (PD) can disrupt the lives of not only the people living with it, but also their care partners. Read more about our commitment to the PD community and advancing research: https://bit.ly/4cOQXLy [Video description: On-screen text states "44% of Parkinson’s disease patients reported that their nighttime symptoms affect their care partners emotionally, and 36% reported that their symptoms disrupt their care partner's sleep and physical well-being.” Followed by a quote from a person living with PD: “Parkinson’s doesn’t take a break. It impacts us 24/7.” On-screen text: “We are proud to sponsor the PD Avengers SLEEP survey.”]